Your browser doesn't support javascript.
loading
Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance.
Pietilä, Elina A; Gonzalez-Molina, Jordi; Moyano-Galceran, Lidia; Jamalzadeh, Sanaz; Zhang, Kaiyang; Lehtinen, Laura; Turunen, S Pauliina; Martins, Tomás A; Gultekin, Okan; Lamminen, Tarja; Kaipio, Katja; Joneborg, Ulrika; Hynninen, Johanna; Hietanen, Sakari; Grénman, Seija; Lehtonen, Rainer; Hautaniemi, Sampsa; Carpén, Olli; Carlson, Joseph W; Lehti, Kaisa.
Afiliação
  • Pietilä EA; Individualized Drug Therapy Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland.
  • Gonzalez-Molina J; Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Moyano-Galceran L; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Jamalzadeh S; Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Zhang K; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Lehtinen L; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Turunen SP; Research Center for Cancer, Infections and Immunity, Institute of Biomedicine, University of Turku, Turku, Finland.
  • Martins TA; Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Gultekin O; Individualized Drug Therapy Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland.
  • Lamminen T; Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Kaipio K; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Joneborg U; Research Center for Cancer, Infections and Immunity, Institute of Biomedicine, University of Turku, Turku, Finland.
  • Hynninen J; Research Center for Cancer, Infections and Immunity, Institute of Biomedicine, University of Turku, Turku, Finland.
  • Hietanen S; Department of Women's and Children's Health, Division Obstetrics and Gynaecology, Karolinska Institutet, Stockholm, Sweden.
  • Grénman S; Department of Pelvic Cancer, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.
  • Lehtonen R; Department of Obstetrics and Gynecology, Turku University Hospital, University of Turku, Turku, Finland.
  • Hautaniemi S; Department of Obstetrics and Gynecology, Turku University Hospital, University of Turku, Turku, Finland.
  • Carpén O; Department of Obstetrics and Gynecology, Turku University Hospital, University of Turku, Turku, Finland.
  • Carlson JW; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Lehti K; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Nat Commun ; 12(1): 3904, 2021 06 23.
Article em En | MEDLINE | ID: mdl-34162871
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Regulação Neoplásica da Expressão Gênica / Cistadenocarcinoma Seroso / Resistencia a Medicamentos Antineoplásicos / Perfilação da Expressão Gênica Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Regulação Neoplásica da Expressão Gênica / Cistadenocarcinoma Seroso / Resistencia a Medicamentos Antineoplásicos / Perfilação da Expressão Gênica Idioma: En Ano de publicação: 2021 Tipo de documento: Article